bioRxiv Science⌕ Search

Biology subjects

Uruena, J. M.

Publications and source records attributed to Uruena, J. M..

2 recordsLinked to original sources

Measurement intensification for antibody formulations: combined measurement of protein size, interactions, and viscosity by differential dynamic microscopy

High-throughput screening and optimization of high-value protein formulations requires intensified measurements to extract a wide range of properties using a small number of measurement techniques, small sample volumes, and short measurement times. We demonstrate how differential dynamic microscopy (DDM) can fill this need by measuring a broad range of key biophysical properties relevant to protein formulations from a single workflow on microliter-scale samples using label-free video optical microscopy. We show that the use of phase contrast imaging dramatically enhances measurement resolution for protein solutions at dilute and semidilute concentrations, enabling measurement of colloidal properties such as protein-protein interactions, protein size, aggregation, and solution viscosity from a single set of measurements. DDM measurements on a representative human immunoglobulin (IgG) system yield estimates for the hydrodynamic radius (Rh), second osmotic virial coefficient (B2), and hydrodynamic interaction (kd) that are consistent with independently measured values, validating the ability of DDM to extract these parameters from a single set of measurements. Observed trends in B2 with pH and ionic strength are consistent with the antibodys charge and screened electrostatics, demonstrating the ability of DDM to provide insight on protein-protein interactions. To show the utility of DDM as a "multitool" for quantifying multiple formulation properties from a single measurement, we use the results to test a predictive colloidal model for the solution viscosity, which is in fair agreement with measurements obtained using DDM-based microrheology. Combined with low sample requirements and short measurement times, DDM thus offers a high-throughput and efficient route to accelerate protein biophysics and formulation development. SIGNIFICANCE STATEMENTThe formulation of stable, high-concentration antibodies and other protein solutions requires extensive biophysical measurements that are often material- and time-intensive. We demonstrate that differential dynamic microscopy (DDM) provides a powerful alternative by providing rapid access to a broad range of industrially relevant colloidal properties from a single measurement on microliter-scale samples using conventional video optical microscopy. This capability makes DDM an attractive, low-resource approach for routine biomolecular formulation screening and optimization.

biophysics↗

In vitro infection of human lung tissue with SARS-CoV-2: Heterogeneity in host defense and therapeutic response

Cell lines are the mainstay in understanding the biology of COVID-19 infection, but do not recapitulate many of the complexities of human infection. The use of human lung tissue is one solution for the study of such novel respiratory pathogens. We hypothesized that a cryopreserved bank of human lung tissue allows for the in vitro study of the inter-individual heterogeneity of host response to SARS-CoV-2 infection, thus providing a bridge between studies with cell lines and studies in animal models. We generated a cryobank of tissues from 16 donors, most of whom had risk factors for severe illness from COVID-19. Cryopreserved tissues preserved 90% of cell viability and contained heterogeneous populations of metabolically active epithelial, endothelial, and immune cell subsets of the human lung. Samples were readily infectible with HCoV-OC43 and SARS-CoV-2 coronavirus strains, and demonstrated comparable susceptibility to infection. In contrast, we observed a marked donor-dependent heterogeneity in the expression of IL-6, CXCL8 and IFN{beta} in response to SARS-CoV-2 infection. Treatment of tissues with dexamethasone and the experimental drug, N-hydroxycytidine, suppressed viral growth in all samples, whereas chloroquine and remdesivir had no detectable effect. Metformin and sirolimus, molecules with predicted antiviral activity, suppressed viral replication in tissues from a subset of donors. In summary, we developed a novel system for the in vitro study of human SARS-CoV-2 infection using primary human lung tissue from a library of donor tissues. This model may be useful for drug screening and for understanding basic mechanisms of COVID-19 pathogenesis. ImportanceThe current biological systems for the study of COVID-19 are in vitro systems that differ from the human lung in many respects, and animal hosts to which the virus is not adapted. We developed another alternative for studying pathogenesis and drug susceptibility of SARS-CoV-2 in a cryopreserved bank of human lung tissues. We consider the importance of this work to relate to the practical use of this culture system as a repeatable and scalable approach that allows for the study of an important infection in relevant tissues. The tissue bank highlights the heterogeneous response to SARS-CoV-2 infection and treatment, which allows researchers to investigate why treatments work in some donors but not others.

microbiology↗